Report cover image

Omega-3 Fatty Acids Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published Dec 01, 2024
Length 204 Pages
SKU # FOB19410754

Description

Omega-3 Fatty Acids Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Omega-3 Fatty Acids Market

The global omega-3 fatty acids market size was valued at USD 1.54 billion in 2020 and is projected to grow from USD 1.62 billion in 2021 to USD 2.24 billion by 2028, exhibiting a CAGR of 4.80% during the forecast period of 2021-2028.

The pandemic affected the omega-three fatty acids industry primarily through disruptions in the delivery chain, the regulation of manufacturing processes, and limited access to raw materials. However, the customer's increasing awareness of fitness benefits and anti-germ houses of omega-3 raised consumers' demand for omega-3 supplements, partially decreasing the poor impact and delaying omega-3 fatty acids market growth.

The omega-3 Fatty Acids Market is driven by the constantly increasing understanding of fitness benefits, emerging recognition of dietary supplements, and escalating usage of goal components, pharmaceuticals, and infant vitamins.

Smart era integration is revolutionizing the sterilization field marketplace. By incorporating RFID and barcode technology, actual-time monitoring and monitoring of sterilization boxes is enabled, improving stock control and decreasing errors, expanding the global omega-3 fatty acids market share. Additionally, superior sensors and statistics logging capabilities allow for tracking essential parameters like temperature, stress, and humidity at some point in the sterilization technique, ensuring effective sterilization and enhancing exemplary management. These improvements make contributions to a more efficient and reliable sterilization process.

Comprehensive Analysis of Omega-3 Fatty Acids Market

The Omega-three Fatty Acids Market is segmented by source and application. The concentrates phase leads the marketplace because of its high purity and wealthy EPA and DHA content. At the same time, alternatives like krill oil, algae, and plant-based resources cater to sustainability and vegetarian demands. By application, nutritional supplements dominate, pushed through their health blessings for coronary heart, brain, and infant improvement, along with advancements in personalized vitamins. Functional ingredients are unexpectedly developing, with growing incorporation in snacks, Little One formulations, or pet food, reflecting growing patron recognition of fitness and well-being.

The North America region led the omega-3 fatty acids market by benefitting a size of USD 0.62 billion in 2020 due to increasing attention to the health advantages associated with polyunsaturated fatty acids. The North American market has experienced a boom.

The leading players in the Omega-3 Fatty Acids Market significantly influence its growth trajectory and set industry standards. These key players, including Royal DSM N.V. (Netherlands), Evonik (Germany), BASF SE (Germany), Lonza (Switzerland), Epax (Norway), Croda International Plc (U.K.), Cargill, Inc. (U.S.), Golden Omega (Chile), Corbion (Netherlands), and Polaris (U.S.), contribute to a competitive landscape, driving innovation and advancing the market through cutting-edge research and product development.

In February 2021, India-based startup OZiva added a new variety of vegan Omega-3 multivitamins to cater to the developing call for plant-based nutritional supplements.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2017-2028

Base Year 2020

Estimated Year 2021

Forecast Period2021-2028

Historical Period 2017-2019

Unit Value (USD Billion)

SegmentationBy Source

Concentrates

Fish Oil

Algae Oil

Krill Oil

Other Plant Sources

By Application

Dietary Supplements

Functional/Fortified Foods

Infant Formulae

Pharmaceuticals

Animal Feed & Pet Food

By Region

North America (By Source, Application, and By Country)

U.S. (By Application)

Canada (By Application)

Mexico (By Application)

Europe (By Source, Application, and By Country)

U.K. (By Application)

France (By Application)

Italy (By Application)

Spain (By Application)

Germany (By Application)

Russia (By Application)

Rest of Europe (By Application)

Asia Pacific (By Source, Application, and By Country)

China (By Application)

India (By Application)

Japan (By Application)

Australia (By Application)

Rest of Asia Pacific (By Application)

South America (By Source, Application, and By Country)

Brazil (By Application)

Argentina (By Application)

Rest of South America (By Application)

Middle East & Africa (By Source, Application, and By Country)

South Africa (By Application)

UAE (By Application)

Rest of MEA (By Application)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

204 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Overview of the Parent/Related Markets
4.2. Industry SWOT Analysis
4.3. Supply Chain and Regulatory Analysis
4.4. Recent Industry Developments - Policies, Partnerships, New Product Launches, and Mergers & Acquisitions
4.5. Market Analysis and Insights (in Relation with COVID-19)
4.5.1. Impact of COVID-19 on the Market
4.5.2. Supply Chain Challenges due to the Pandemic
4.5.3. Potential Opportunities Due to COVID-19
5. Global Omega-3 Fatty Acids Market Analysis, Insights and Forecast, 2017-2028
5.1. Key Findings / Summary
5.2. Market Size Estimates and Forecast
5.2.1. By Source
5.2.1.1. Concentrates
5.2.1.2. Fish Oil
5.2.1.3. Algae Oil
5.2.1.4. Krill Oil
5.2.1.5. Other Plant Sources
5.2.2. By Application
5.2.2.1. Dietary Supplements
5.2.2.2. Functional/Forified Foods
5.2.2.3. Infant Formulae
5.2.2.4. Pharmaceuticals
5.2.2.5. Animal Feed & Pet Food
5.2.3. By Region
5.2.3.1. North America
5.2.3.2. Europe
5.2.3.3. Asia Pacific
5.2.3.4. South America
5.2.3.5. Middle East & Africa
6. North America Omega-3 Fatty Acids Market Analysis, Insights and Forecast, 2017-2028
6.1. Key Findings / Summary
6.2. Market Size Estimates and Forecast
6.2.1. By Source
6.2.1.1. Concentrates
6.2.1.2. Fish Oil
6.2.1.3. Algae Oil
6.2.1.4. Krill Oil
6.2.1.5. Other Plant Sources
6.2.2. By Application
6.2.2.1. Dietary Supplements
6.2.2.2. Functional/Forified Foods
6.2.2.3. Infant Formulae
6.2.2.4. Pharmaceuticals
6.2.2.5. Animal Feed & Pet Food
6.2.3. By Country (Value)
6.2.3.1. The U.S.
6.2.3.1.1. By Application(Value)
6.2.3.1.1.1. Dietary Supplements
6.2.3.1.1.2. Functional/Forified Foods
6.2.3.1.1.3. Infant Formulae
6.2.3.1.1.4. Pharmaceuticals
6.2.3.1.1.5. Animal Feed & Pet Food
6.2.3.2. Canada
6.2.3.2.1. By Application(Value)
6.2.3.2.1.1. Dietary Supplements
6.2.3.2.1.2. Functional/Forified Foods
6.2.3.2.1.3. Infant Formulae
6.2.3.2.1.4. Pharmaceuticals
6.2.3.2.1.5. Animal Feed & Pet Food
6.2.3.3. Mexico
6.2.3.3.1. By Application(Value)
6.2.3.3.1.1. Dietary Supplements
6.2.3.3.1.2. Functional/Forified Foods
6.2.3.3.1.3. Infant Formulae
6.2.3.3.1.4. Pharmaceuticals
6.2.3.3.1.5. Animal Feed & Pet Food
7. Europe Omega-3 Fatty Acids Market Analysis, Insights and Forecast, 2017-2028
7.1. Key Findings / Summary
7.2. Market Size Estimates and Forecast
7.2.1. By Source
7.2.1.1. Concentrates
7.2.1.2. Fish Oil
7.2.1.3. Algae Oil
7.2.1.4. Krill Oil
7.2.1.5. Other Plant Sources
7.2.2. By Application
7.2.2.1. Dietary Supplements
7.2.2.2. Functional/Forified Foods
7.2.2.3. Infant Formulae
7.2.2.4. Pharmaceuticals
7.2.2.5. Animal Feed & Pet Food
7.2.3. By Country (Value)
7.2.3.1. Germany
7.2.3.1.1. By Application(Value)
7.2.3.1.1.1. Dietary Supplements
7.2.3.1.1.2. Functional/Forified Foods
7.2.3.1.1.3. Infant Formulae
7.2.3.1.1.4. Pharmaceuticals
7.2.3.1.1.5. Animal Feed & Pet Food
7.2.3.2. France
7.2.3.2.1. By Application(Value)
7.2.3.2.1.1. Dietary Supplements
7.2.3.2.1.2. Functional/Forified Foods
7.2.3.2.1.3. Infant Formulae
7.2.3.2.1.4. Pharmaceuticals
7.2.3.2.1.5. Animal Feed & Pet Food
7.2.3.3. Italy
7.2.3.3.1. By Application(Value)
7.2.3.3.1.1. Dietary Supplements
7.2.3.3.1.2. Functional/Forified Foods
7.2.3.3.1.3. Infant Formulae
7.2.3.3.1.4. Pharmaceuticals
7.2.3.3.1.5. Animal Feed & Pet Food
7.2.3.4. U.K.
7.2.3.4.1. By Application(Value)
7.2.3.4.1.1. Dietary Supplements
7.2.3.4.1.2. Functional/Forified Foods
7.2.3.4.1.3. Infant Formulae
7.2.3.4.1.4. Pharmaceuticals
7.2.3.4.1.5. Animal Feed & Pet Food
7.2.3.5. Spain
7.2.3.5.1. By Application(Value)
7.2.3.5.1.1. Dietary Supplements
7.2.3.5.1.2. Functional/Forified Foods
7.2.3.5.1.3. Infant Formulae
7.2.3.5.1.4. Pharmaceuticals
7.2.3.5.1.5. Animal Feed & Pet Food
7.2.3.6. Rest of Europe
7.2.3.6.1. By Application(Value)
7.2.3.6.1.1. Dietary Supplements
7.2.3.6.1.2. Functional/Forified Foods
7.2.3.6.1.3. Infant Formulae
7.2.3.6.1.4. Pharmaceuticals
7.2.3.6.1.5. Animal Feed & Pet Food
8. Asia Pacific Omega-3 Fatty Acids Market Analysis, Insights and Forecast, 2017-2028
8.1. Key Findings / Summary
8.2. Market Size Estimates and Forecast
8.2.1. By Source
8.2.1.1. Concentrates
8.2.1.2. Fish Oil
8.2.1.3. Algae Oil
8.2.1.4. Krill Oil
8.2.1.5. Other Plant Sources
8.2.2. By Application
8.2.2.1. Dietary Supplements
8.2.2.2. Functional/Forified Foods
8.2.2.3. Infant Formulae
8.2.2.4. Pharmaceuticals
8.2.2.5. Animal Feed & Pet Food
8.2.3. By Country (Value)
8.2.3.1. China
8.2.3.1.1. By Application(Value)
8.2.3.1.1.1. Dietary Supplements
8.2.3.1.1.2. Functional/Forified Foods
8.2.3.1.1.3. Infant Formulae
8.2.3.1.1.4. Pharmaceuticals
8.2.3.1.1.5. Animal Feed & Pet Food
8.2.3.2. India
8.2.3.2.1. By Application(Value)
8.2.3.2.1.1. Dietary Supplements
8.2.3.2.1.2. Functional/Forified Foods
8.2.3.2.1.3. Infant Formulae
8.2.3.2.1.4. Pharmaceuticals
8.2.3.2.1.5. Animal Feed & Pet Food
8.2.3.3. Japan
8.2.3.3.1. By Application(Value)
8.2.3.3.1.1. Dietary Supplements
8.2.3.3.1.2. Functional/Forified Foods
8.2.3.3.1.3. Infant Formulae
8.2.3.3.1.4. Pharmaceuticals
8.2.3.3.1.5. Animal Feed & Pet Food
8.2.3.4. Australia
8.2.3.4.1. By Application(Value)
8.2.3.4.1.1. Dietary Supplements
8.2.3.4.1.2. Functional/Forified Foods
8.2.3.4.1.3. Infant Formulae
8.2.3.4.1.4. Pharmaceuticals
8.2.3.4.1.5. Animal Feed & Pet Food
8.2.3.5. Rest of Asia Pacific
8.2.3.5.1. By Application(Value)
8.2.3.5.1.1. Dietary Supplements
8.2.3.5.1.2. Functional/Forified Foods
8.2.3.5.1.3. Infant Formulae
8.2.3.5.1.4. Pharmaceuticals
8.2.3.5.1.5. Animal Feed & Pet Food
9. South America Omega-3 Fatty Acids Market Analysis, Insights and Forecast, 2017-2028
9.1. Key Findings / Summary
9.2. Market Size Estimates and Forecast
9.2.1. By Source
9.2.1.1. Concentrates
9.2.1.2. Fish Oil
9.2.1.3. Algae Oil
9.2.1.4. Krill Oil
9.2.1.5. Other Plant Sources
9.2.2. By Application
9.2.2.1. Dietary Supplements
9.2.2.2. Functional/Forified Foods
9.2.2.3. Infant Formulae
9.2.2.4. Pharmaceuticals
9.2.2.5. Animal Feed & Pet Food
9.2.3. By Country (Value)
9.2.3.1. Brazil
9.2.3.1.1. By Application(Value)
9.2.3.1.1.1. Dietary Supplements
9.2.3.1.1.2. Functional/Forified Foods
9.2.3.1.1.3. Infant Formulae
9.2.3.1.1.4. Pharmaceuticals
9.2.3.1.1.5. Animal Feed & Pet Food
9.2.3.2. Argentina
9.2.3.2.1. By Application(Value)
9.2.3.2.1.1. Dietary Supplements
9.2.3.2.1.2. Functional/Forified Foods
9.2.3.2.1.3. Infant Formulae
9.2.3.2.1.4. Pharmaceuticals
9.2.3.2.1.5. Animal Feed & Pet Food
9.2.3.3. Rest of South America
9.2.3.3.1. By Application(Value)
9.2.3.3.1.1. Dietary Supplements
9.2.3.3.1.2. Functional/Forified Foods
9.2.3.3.1.3. Infant Formulae
9.2.3.3.1.4. Pharmaceuticals
9.2.3.3.1.5. Animal Feed & Pet Food
10. Middle East & Africa Omega-3 Fatty Acids Market Analysis, Insights and Forecast, 2017-2028
10.1. Key Findings / Summary
10.2. Market Size Estimates and Forecast
10.2.1. By Source
10.2.1.1. Concentrates
10.2.1.2. Fish Oil
10.2.1.3. Algae Oil
10.2.1.4. Krill Oil
10.2.1.5. Other Plant Sources
10.2.2. By Application
10.2.2.1. Dietary Supplements
10.2.2.2. Functional/Forified Foods
10.2.2.3. Infant Formulae
10.2.2.4. Pharmaceuticals
10.2.2.5. Animal Feed & Pet Food
10.2.3. By Country (Value)
10.2.3.1. South Africa
10.2.3.1.1. By Application(Value)
10.2.3.1.1.1. Dietary Supplements
10.2.3.1.1.2. Functional/Forified Foods
10.2.3.1.1.3. Infant Formulae
10.2.3.1.1.4. Pharmaceuticals
10.2.3.1.1.5. Animal Feed & Pet Food
10.2.3.2. UAE
10.2.3.2.1. By Application(Value)
10.2.3.2.1.1. Dietary Supplements
10.2.3.2.1.2. Functional/Forified Foods
10.2.3.2.1.3. Infant Formulae
10.2.3.2.1.4. Pharmaceuticals
10.2.3.2.1.5. Animal Feed & Pet Food
10.2.3.3. Rest of Middle East & Africa
10.2.3.3.1. By Application(Value)
10.2.3.3.1.1. Dietary Supplements
10.2.3.3.1.2. Functional/Forified Foods
10.2.3.3.1.3. Infant Formulae
10.2.3.3.1.4. Pharmaceuticals
10.2.3.3.1.5. Animal Feed & Pet Food
11. Competitive Matrix
11.1. Business Strategies Adopted by Leading Players
11.2. Global Omega-3 Fatty Acids Market Revenue Share/Ranking Analysis, By Key Manufacturer, 2020
12. Company Profiles
12.1. Royal DSM N.V.
12.1.1. Overview
12.1.2. Description
12.1.3. Source Portfolio
12.1.4. Financials (Data as available in public domain and/or on paid databases)
12.1.5. Recent Developments
12.2. Evonik
12.2.1. Overview
12.2.2. Description
12.2.3. Source Portfolio
12.2.4. Financials (Data as available in public domain and/or on paid databases)
12.2.5. Recent Developments
12.3. BASF SE
12.3.1. Overview
12.3.2. Description
12.3.3. Source Portfolio
12.3.4. Financials (Data as available in public domain and/or on paid databases)
12.3.5. Recent Developments
12.4. Lonza
12.4.1. Overview
12.4.2. Description
12.4.3. Source Portfolio
12.4.4. Financials (Data as available in public domain and/or on paid databases)
12.4.5. Recent Developments
12.5. Epax
12.5.1. Overview
12.5.2. Description
12.5.3. Source Portfolio
12.5.4. Financials (Data as available in public domain and/or on paid databases)
12.5.5. Recent Developments
12.6. Croda International, Plc
12.6.1. Overview
12.6.2. Description
12.6.3. Source Portfolio
12.6.4. Financials (Data as available in public domain and/or on paid databases)
12.6.5. Recent Developments
12.7. Cargill, Inc
12.7.1. Overview
12.7.2. Description
12.7.3. Source Portfolio
12.7.4. Financials (Data as available in public domain and/or on paid databases)
12.7.5. Recent Developments
12.8. Golden Omega
12.8.1. Overview
12.8.2. Description
12.8.3. Source Portfolio
12.8.4. Financials (Data as available in public domain and/or on paid databases)
12.8.5. Recent Developments
12.9. Corbion
12.9.1. Overview
12.9.2. Description
12.9.3. Source Portfolio
12.9.4. Financials (Data as available in public domain and/or on paid databases)
12.9.5. Recent Developments
12.10. Polaris
12.10.1. Overview
12.10.2. Description
12.10.3. Source Portfolio
12.10.4. Financials (Data as available in public domain and/or on paid databases)
12.10.5. Recent Developments
13. Appendix

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us